Oncological pathology

Morales Murillo, Serafin; Gasol Cudos, Ariadna; Veas Rodriguez, Joel; Canosa Morales, Carles; Melé Olivé, Jordi; Vilardell Villellas, Felip; Sanchez Guzman, Douglas Rene; Iglesias Martínez, Edelmiro; Salud Salvia, Antonieta

Selection of neoadjuvant treatment based on the 21-GENE test results in luminal breast cancer

BREAST 56 35-41. 01/03/2021.

[doi:10.1016/j.breast.2021.01.001]

Concin N; Matias-Guiu X; Vergote I; Cibula D; Mirza MR; Marnitz S; Ledermann J; Bosse T; Chargari C; Fagotti A; Fotopoulou C; Martin AG; Lax S; Lorusso D; Marth C; Morice P; Nout RA; O'Donnell D; Querleu D; Raspollini MR; Sehouli J; Sturdza A; Taylor A; Westermann A; Wimberger P; Colombo N; Planchamp F; Creutzberg CL

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.

RADIOTHERAPY AND ONCOLOGY 154 327-353. 01/03/2021.

[doi:10.1016/j.radonc.2020.11.018]

Bosse, T; Lax, S; Abu-Rustum, N; Matias-Guiu, X

The Role of Predictive Biomarkers in Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists

INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 40 102-110. 01/03/2021.

[doi:10.1097/PGP.0000000000000755]

Murillo, SM; Cudos, AG; Rodriguez, JV; Morales, CC; Olive, JM; Villellas, FV; Guzman, DRS; Martinez, EI; Salvia, AS

Survival analysis of bevacizumab plus taxane treatment in luminal metastatic breast cancer

Future Science Oa 7 -. 01/03/2021.

[doi:10.2144/fsoa-2020-0146]

Concin N; Creutzberg CL; Vergote I; Cibula D; Mirza MR; Marnitz S; Ledermann JA; Bosse T; Chargari C; Fagotti A; Fotopoulou C; González-Martín A; Lax SF; Lorusso D; Marth C; Morice P; Nout RA; O'Donnell DE; Querleu D; Raspollini MR; Sehouli J; Sturdza AE; Taylor A; Westermann AM; Wimberger P; Colombo N; Planchamp F; Matias-Guiu X

ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.

VIRCHOWS ARCHIV 478 153-190. 01/02/2021.

[doi:10.1007/s00428-020-03007-z]

Frias-Gomez J; Peremiquel-Trillas P; Alemany L; Ameijide A; Marcos-Gragera R; Ponce J; Brunet J; Matias-Guiu X; Galceran J; Izquierdo Á; Borràs JM; Costas L; Clèries R

Predicting the rising incidence and mortality of endometrial cancers among women aged 65-74 years in Catalonia.

MATURITAS 144 11-15. 01/02/2021.

[doi:10.1016/j.maturitas.2020.09.006]

Murillo, SM; Cudos, AG; Subirats, OP; Olive, JM; Morales, CC; Villellas, FV; Guzman, DRS; Rodriguez, JV; Galindo, AR

Axillary management after neoadjuvant chemotherapy in initially node positive early breast cancer

CANCER RESEARCH 81 -. 01/02/2021.

Concin N; Matias-Guiu X; Vergote I; Cibula D; Mirza MR; Marnitz S; Ledermann J; Bosse T; Chargari C; Fagotti A; Fotopoulou C; Gonzalez Martin A; Lax S; Lorusso D; Marth C; Morice P; Nout RA; O'Donnell D; Querleu D; Raspollini MR; Sehouli J; Sturdza A; Taylor A; Westermann A; Wimberger P; Colombo N; Planchamp F; Creutzberg CL

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 31 12-39. 01/01/2021.

[doi:10.1136/ijgc-2020-002230]

Ojanguren A; Santamaría M; Milla-Collado L; Fraile C; Gatius-Calderó S; Puy S; Boldó A; Gómez-Olles S; Boada-Pérez M; Esquinas C; Sáez-Giménez B; Ojanguren I; Barrecheguren M; Olsina-Kissler JJ

Pilot Trial of Extended Hypothermic Lung Preservation to Analyze Ischemia-reperfusion Injury in Pigs.

ARCHIVOS DE BRONCONEUMOLOGIA 57 479-489. 01/01/2021.

[doi:10.1016/j.arbres.2021.03.008]

Cudos, AG; Murillo, SM; Subirats, OP; Villellas, FV; Guzman, DRS; Morales, CC; Olive, JM; Sanchez, AV; Ortega, JFC

Relapse pattern after neoadjuvant treatment in early breast cancer

ANNALS OF ONCOLOGY 32 437-437. 01/01/2021.

[doi:10.1016/j.annonc.2021.08.461]

Nicolas-Sanchez, FJ; Arostegui-Gorospe, JI; Pallares-Quixal, J; Nicolas-Sarrat, FJ; Sarrat-Nuevo, RM; Bou, RMN; Melgarejo-Moreno, PJ

p.RQ92 mutation associated with amyloidosis

REUMATOLOGIA CLINICA 17 46-48. 01/01/2021.

[doi:10.1016/j.reuma.2019.07.006]

MATIAS-GUIU GUIA, XAVIER

Endometrial Cancer Histopathology Reporting Guide

Endometrial Cancer Histopathology Reporting Guide -. 01/01/2021.